Back to results
US 2023/0057598 A1Published application
Screening kit for paroxysmal supraventricular tachycardia
AssigneesSichuan Provincial People's Hospital, Chengdu Medical College, Nanjing Ysy Biotech Company Ltd.
InventorsXiaoping LI, Rong LUO, Qingshun ZHAO, Zhenglin YANG, Tao HE, Mingjiang LIU
Life of this patent
Estimating the term…
Abstract
A screening kit for paroxysmal supraventricular tachycardia contains a reagent for detecting a human CACNA1B gene c. 1700A>G mutation site at base No. 1700 in a coding region of CACNA1B gene from A to G.
Claims4
1-10. (canceled)
Use of a reagent for detecting the c.1700A>G mutation site of human CACNA1B gene in the preparation of a screening kit for atrioventricular nodal reentrant tachycardia, characterized in that the sequence of the human CACNA1B gene is represented by SEQ ID NO:
- 3.
Dependencies are inferred from the claim text.